FindTrial
Sign In

Tegafur-Gimeracil-Oteracil

DRUG5 trials

Sponsors

Zhejiang Cancer Hospital, National Taiwan University Hospital, Fudan University, Zhejiang University, The First Affiliated Hospital of Zhengzhou University

Conditions

AdenocarcinomaAdjuvant TherapyChemoradiotherapyChemotherapy EffectEsophagogastric Junction DisorderGastrectomyImmunotherapyLocally Advanced Gastric Adenocarcinoma

Phase 2

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis
NCT03904225
Zhejiang Cancer HospitalNasopharyngeal Carcinoma
Start: 2018-12-14End: 2022-12-31Target: 220Updated: 2021-06-23
Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer
NCT04377048
National Taiwan University HospitalStage IV Pancreatic Cancer
Start: 2020-07-01End: 2022-12-31Target: 38Updated: 2020-05-06
Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer
TerminatedNCT05161572
Fudan UniversityAdenocarcinoma, Adjuvant Therapy, Chemoradiotherapy +5
Start: 2021-09-28End: 2022-09-30Updated: 2025-06-18
A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ Adenocarcinoma
Not yet recruitingNCT07828873
The First Affiliated Hospital of Zhengzhou UniversityLocally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Start: 2026-11-01End: 2029-12-01Target: 34Updated: 2026-09-18

Phase 3

Study of Comparing of With and Without Sequential Therapy of S-1
RecruitingNCT05813015
Zhejiang UniversityChemotherapy Effect, Locally Advanced Gastric Adenocarcinoma
Start: 2023-01-28End: 2026-12-31Target: 70Updated: 2023-04-14

Related Papers

Incorporating nivolumab with preceded gemcitabine and S-1 chemotherapy for patients of metastatic pancreatic cancer: a pilot study.
2025-09-25
A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRacing study.
2022-06-281 citations